Back

Urgent surgery compared to fibrinolytic therapy for the treatment of left-sided mechanical valve thrombosis (SAFE-PVT): a randomized controlled trial

2 September 2024 (09:11 - 09:22)
Organised by: Logo
Congress Presentation Part of: Smaller trials and trial updates on shock, surgery, and other interventions Surgery ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Ganesan Karthikeyan

All India Institute of Medical Sciences AIIMS New Delhi, New Delhi (India)

7 More presentations in this session

Presentation thumbnail
Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock - 12 months results of the ECLS-SHOCK trial
Professor S. Desch (Leipzig, DE)
Slides Video
Presentation thumbnail
Impact of baseline surgical risk on the treatment effect of PCI and CABG in ischemic left ventricular systolic dysfunction: results of the REVIVED-BCIS2 and STICH randomized controlled trials
Doctor G. Marquis-Gravel (Montreal, CA)
Slides Video
Presentation thumbnail
Empagliflozin for prevention of acute kidney injury in patients with type 2 diabetes mellitus undergoing extracorporeal on-pump CABG: The POST-CABGDM trial
Doctor F. Pitta (Sao Paulo, BR)
Slides Video
Presentation thumbnail
Comparative Effectiveness of Percutaneous and Surgical Revascularisation in Ischaemic Left Ventricular Systolic Dysfunction: Combined Patient-Level Analysis of the REVIVED-BCIS2 and STICH Trials
Doctor M. Ryan (London, GB)
Slides Video
Presentation thumbnail
Temporary mechanical circulatory support in infarct-related cardiogenic shock - An individual patient data meta-analysis of all randomized trials with 6-month follow-up
Professor H. Thiele (Leipzig, DE)
Slides Video

Access the full session

Session thumbnail
Smaller trials and trial updates on shock, surgery, and other interventions
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 09:11 CET
You may be interested in
thumbnail
Congress Presentation
Recombinant tissue plasminogen activator as a modifier of treatment effect in prosthetic valve thrombosis: systematic review and meta-regression
thumbnail
Congress Presentation
Surgery versus thrombolytic therapy for the management of left-sided prosthetic valve thrombosis without hemodynamic compromise: a systematic review and meta-analysis
thumbnail
Congress Presentation
Efficacy and safety of the ultraslow low-dose thrombolytic regimen for mechanical prosthetic valve thrombosis: a prospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources